Items where Funder is Pharma Mar.
Up a levelFAISAL AL-TERKAIT
Ray-Coquard, I, Hatcher, H, Bompas, E et al. (16 more authors) (2020) A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113). International Journal of Gynecological Cancer. ISSN 1048-891X
UK JG 08-102015 SM
Ray-Coquard, I, Hatcher, H, Bompas, E et al. (16 more authors) (2020) A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113). International Journal of Gynecological Cancer. ISSN 1048-891X
Pantaleo, MA, Heinrich, MC, Italiano, A et al. (11 more authors) (2022) A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor. BMC Cancer, 22 (1). 511. 511-. ISSN 1471-2407